Logo Lanfrica
  • Accueil
  • Atlas
  • Analyses
  • Documentation
  • Sign in

© 2026 Lanfrica. Tous droits réservés. Tous les droits d'auteur des ressources affichées sur le site Web Lanfrica appartiennent aux détenteurs de droits d'auteur d'origine, sauf indication contraire explicite.

Benchmarking Cross-ancestry Polygenic Score Methods in a Large Sample of Ancestrally Diverse Adolescents from the ABCD Study?

Domaine:

healthcare

Type de record:

paper
Créateur:
AheAhe
Éditeur:
ThoFanLou
Éditeur:
NIM
Hôte:avatar
Using individuals? genetic data researchers can generate Polygenic Scores (PS) that are able to predict risk for diseases, variability in different behaviors as well as anthropomorphic measures. This is achieved by leveraging models learned from previously published large Genome-Wide Association Studies (GWASs) associating locations in the genome with a phenotype of interest. Previous GWASs have predominantly been performed in European ancestry individuals. This is of concern as PS generated in samples with a different ancestry to the original training GWAS have been shown to have lower performance and limited portability, and many efforts are now underway to collect genetic databases on individuals of diverse ancestries. In this study, we compare multiple methods of generating PS, including pruning and thresholding and bayesian continuous shrinkage models, to see which of them is best able to overcome these limitations. To do this we use the ABCD Study, a longitudinal cohort with deep phenotyping on individuals of diverse ancestry. We generate PS for anthropometric and psychiatric phenotypes using previously published GWA summary statistics and examine their performance in three subsamples of ABCD: African ancestry individuals (n=811), European ancestry Individuals (n=6,703), and admixed ancestry individuals (n=3,664). We find that the continuous shrinkage methods, PRScs and PRScsx Meta, show the best performance across ancestries and phenotypes.

Visit

doi.orgnda.nih.gov

Tags

Polygenic ScoreABCDHeightWeightDepressionSchizophreniaAdmixeddiverse

Similaires

Multi-Ancestry Polygenic Risk Score for Coronary Heart Disease Based on an Ancestrally Diverse Genome-Wide Association Study and Population-Specific OptimizationDevelopment and validation of a trans-ancestry polygenic risk score for type 2 diabetes in diverse populationsRisk factors affecting polygenic score performance across diverse cohortsPerformance of African-ancestry-specific polygenic hazard score varies according to local ancestry in 8q24Pharmacokinetics and pharmacogenomics of clozapine in an ancestrally diverse sample: A longitudinal analysis and GWAS using clinical monitoring data from the UKAnalysis of polygenic risk score usage and performance in diverse human populations

Multi-Ancestry Polygenic Risk Score for Coronary Heart Disease Based on an Ancestrally Diverse Genome-Wide Association Study and Population-Specific Optimization

BACKGROUND: Predictive performance of polygenic risk sc

Development and validation of a trans-ancestry polygenic risk score for type 2 diabetes in diverse populations

Abstract Background Type 2 diabetes (T2D) is a worldwide scourge caused by both genetic and environm

Risk factors affecting polygenic score performance across diverse cohorts

Abstract Apart from ancestry, personal or environmental covaria

Performance of African-ancestry-specific polygenic hazard score varies according to local ancestry in 8q24

International audience Background: We previously developed an African-ancestry-specif

Pharmacokinetics and pharmacogenomics of clozapine in an ancestrally diverse sample: A longitudinal analysis and GWAS using clinical monitoring data from the UK

Background The antipsychotic clozapine is the only drug with proven effectivenes

Analysis of polygenic risk score usage and performance in diverse human populations

Abstract A historical tendency to use European ancestry sam